Efficacy of progesterone for moderate to severe traumatic brain injury: A meta-analysis of randomized clinical trials

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lin, Chao ^a   He, Hongquan ^b   Li, Zheng ^a   Liu, Yinglong ^a   Chao, Honglu ^a   Ji, Jing ^a   Liu, Ning ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Neurosurgery Gaochun Hospital ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT; PROGESTERONE;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; CAUSALITY; COMORBIDITY; CONVALESCENCE; DRUG EFFECTS; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PERSISTENT VEGETATIVE STATE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; CAUSALITY; COMORBIDITY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PERSISTENT VEGETATIVE STATE; PREVALENCE; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84940035765     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13442     Document Type: Article

References (33)

1. Ghajar, J. Traumatic brain injury. Lancet 356, 923-929 (2000).
2. Maas, A. I., Stocchetti, N., Bullock, R. Moderate and severe traumatic brain injury in adults. Lancet Neurol 7, 728-741 (2008).
3. Coronado, V. G. et al. Trends in Traumatic Brain Injury in the U.S. and the public health response: 1995-2009. J Safety Res 43, 299-307 (2012).
4. Langlois, J. A., Rutland-Brown, W., Wald, M. M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 21, 375-378 (2006).
5. Stein, D. G., Wright, D. W., Kellermann, A. L. Does progesterone have neuroprotective properties. Ann Emerg Med 51, 164-172 (2008).
6. Pascual, J. L. et al. Neuroprotective effects of progesterone in traumatic brain injury: blunted in vivo neutrophil activation at the blood-brain barrier. Am J Surg 206, 840-845 (2013).
7. Si, D. et al. Progesterone treatment improves cognitive outcome following experimental traumatic brain injury in rats. Neurosci Lett 553, 18-23 (2013).
8. Xiao, G., Wei, J., Yan, W., Wang, W., Lu, Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12, R61 (2008).
9. Skolnick, B. E. et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med 371, 2467-2476 (2014).
10. Xiao, G. M. et al. [Clinical study on the therapeutic effects and mechanism of progesterone in the treatment for acute severe head injury]. Zhonghua Wai Ke Za Zhi 45, 106-108 (2007).
11. Aminmansour, B. et al. Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group. Adv Biomed Res 1, 58 (2012).
12. Shakeri, M. et al. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma. Clin Neurol Neurosurg 115, 2019-2022 (2013).
13. Wright, D. W. et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49, 391-402 (2007).
14. Wright, D. W. et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med 371, 2457-2466 (2014).
15. Maas, A. I., Stocchetti, N., Bullock, R. Moderate and severe traumatic brain injury in adults. Lancet Neurol 7, 728-741 (2008).
16. Mustafa, A. G., Alshboul, O. A. Pathophysiology of traumatic brain injury. Neurosciences (Riyadh) 18, 222-234 (2013).
17. Park, E., Bell, J. D., Baker A. J. Traumatic brain injury: can the consequences be stopped? CMAJ 178, 1163-1170 (2008).
18. Margulies, S., Hicks, R. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma 26, 925-939 (2009).
19. Drew, P. D., Chavis, J. A. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol 111, 77-85 (2000).
20. He, J., Hoffman, S. W., Stein, D. G. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci 22, 19-31 (2004).
21. Cutler, S. M. et al. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 24, 1475-1486 (2007).
22. Li, Z. et al. Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats. J Neurotrauma 29, 343-353 (2012).
23. Ma, J., Huang, S., Qin, S., You, C. Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev 10, CD008409 (2012).
24. Narayan, R. K. et al. Clinical trials in head injury. J Neurotrauma 19, 503-557 (2002).
25. Schouten, J. W. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr Opin Crit Care 13, 134-142 (2007).
26. Loane, D. J., Faden, A. I. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci. 31, 596-604 (2010).
27. Maas, A. I., Roozenbeek, B., Manley, G. T. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 7, 115-126 (2010).
28. Manley, G. T., Maas, A. I. Traumatic brain injury: an international knowledge-based approach. JAMA 310, 473-474 (2013).
29. Wilson, J. T., Pettigrew, L. E., Teasdale, G. M. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15, 573-585 (1998).
30. Higgins, J. P. et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011).
31. Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151, W65-94 (2009).
32. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097 (2009).
33. Egger, M., Davey, S. G., Schneider, M., Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).